Abstract

“Antibody-breeding” has provided therapeutic/diagnostic antibody mutants with greater performance than native antibodies. Typically, random point mutations are introduced into the VH and VL domains of parent antibodies to generate diverse libraries of single-chain Fv fragments (scFvs), from which evolved mutants are selected. We produced an scFv against estradiol-17β with 11 amino acid substitutions and a >100-fold improved affinity constant (Ka = 1.19 × 1010 M−1) over the parent scFv, enabling immunoassays with >30-fold higher sensitivity. We systematically analyzed contributions of these substitutions to the affinity enhancement. Comparing various partial scFv revertants based on their Kas indicated that a revertant with four substitutions (VH-L100gQ, VL-I29V, -L36M, -S77G) exhibited somewhat higher affinity (Ka = 1.46 × 1010 M−1). Finally, the VH-L100gQ substitution, occurring in VH complementarity-determining region (CDR) 3, was found to be the highest-priority for improving the affinity, and VL-I29V and/or VL-L36M cooperated significantly. These findings encouraged us to reconsider the potential of VH-CDR3-targeting mutagenesis, which has been frequently attempted. The substitution(s) wherein might enable a “high rate of return” in terms of selecting mutants with dramatically enhanced affinities. The “high risk” of generating a tremendous excess of “junk mutants” can be overcome with the efficient selection systems that we developed.

Highlights

  • Revolutionary strategies are required for efficiently introducing functional mutations without unnecessarily enlarging the diversity and for reliably selecting rare and improved mutants without overlooking them

  • Essential for elevating the antigen-binding affinity. It would be of great help if it were possible to discover “hot spots” in the VH and/or VL domains of antibodies, where a wide range of mutations introduced thereto significantly improves the affinity

  • It is more desirable if fewer mutations introduced in a narrower region facilitate isolating improved species with high probability

Read more

Summary

Introduction

Among the affinity-matured products reported, mutant scFvs or Fabs that showed Ka values greater than 1 × 109 M−1 (i.e., a standard value required for subpicomole-order analysis), owing to>10-fold enhancement, were selected and their structures are illustrated in Supplementary Fig. S1A. Because two of these four mutants (i.e., anti-fluorescein-biotin and anti-fluorescein antibody fragments) were generated via error-prone PCR18 or related methods, only some of the multiple substitutions introduced might have driven the enhanced affinity.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.